Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR6 | P51684 | 1/20 | 0.61 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.61 |
| ▸ | REN | P00797 | 1/20 | 0.46 |
| ▸ | HDAC1 | Q13547 | 5/20 | 0.45 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.45 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.45 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.45 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.45 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.45 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.45 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.45 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | CNR2 | P34972 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19018818 | 1.00 | CCR6 (0.61) | CCR6PAX8RENHDAC1HDAC6 | |
| SCHEMBL15582141 | 1.00 | CCR6 (0.61) | CCR6PAX8RENHDAC1HDAC6 | |
| SCHEMBL16586897 | 0.99 | CCR6 (0.63) | CCR6PAX8RENHDAC1HDAC6 | |
| SCHEMBL16585962 | 0.94 | CCR6 (0.60) | CCR6PAX8RENHDAC1HDAC6 | |
| Benzoic Acid SCHEMBL21326210 | 0.94 | CCR6 (0.55) | CCR6PAX8RENHDAC1HDAC6 | |
| SCHEMBL14823650 | 0.88 | CCR6 (0.56) | CCR6PAX8RENHDAC1HDAC6 | |
| SCHEMBL21326213 | 0.87 | CCR6 (0.56) | CCR6PAX8RENHDAC1HDAC3 | |
| SCHEMBL7864948 | 0.86 | CCR6 (0.62) | CCR6PAX8ALDH1A1KMT2ACNR2 | |
| SCHEMBL10822929 | 0.86 | CCR6 (0.62) | CCR6PAX8ALDH1A1KMT2ACNR2 | |
| SCHEMBL8029008 | 0.86 | CCR6 (0.56) | CCR6PAX8RENHDAC1HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250282806-A1 | CHEMICAL SYNTHESIS METHOD FOR DISACCHARIDE FRAGMENT OF VIBRIO VULNIFICUS BIOTYPE 2 SEROVAR A O-ANTIGEN | JIANGNAN UNIVERSITY (CN) | 2025-09-11 | — | — | US | disclosed |
| CN-118496286-A | Chemical synthesis method of vibrio vulnificus organism type 2A serotype O-antigen disaccharide fragment | 江南大学 | 2024-08-16 | — | — | CN | disclosed |
| US-11603416-B2 | Method for preparation of derivatives of gram-positive bacteria surface capsular polysaccharide | JIANGNAN UNIVERSITY (CN) | 2023-03-14 | — | — | US | disclosed |
| US-11332490-B1 | Compounds and methods for treating osteoarthritis | ACADEMIA SINICA (TW) | 2022-05-17 | — | — | US | disclosed |
| US-10669353-B2 | Preparation method of outer core octasaccharide of Helicobacter pylori lipopolysaccharide | JIANGNAN UNIVERSITY (CN) | 2020-06-02 | — | — | US | disclosed |
| US-20190177441-A1 | Preparation Method of Outer Core Octasaccharide of Helicobacter Pylori Lipopolysaccharide | Max Planck Institute of Colloids and Interfaces (DE) | 2019-06-13 | — | — | US | disclosed |
| US-10174132-B2 | Heparan sulfate synthesis | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2019-01-08 | — | — | US | disclosed |
| US-10052373-B2 | Protein and peptide-free synthetic vaccines against Streptococcus pneumoniae type 3 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2018-08-21 | — | — | US | disclosed |
| EP-3046587-B1 | PROTEIN AND PEPTIDE-FREE SYNTHETIC VACCINES AGAINST STREPTOCOCCUS PNEUMONIAE TYPE 3 | MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WSS (DE) | 2018-01-31 | — | — | EP | disclosed |
| US-20170333545-A1 | VACCINES AGAINST STREPTOCOCCUS PNEUMONIAE SEROTYPE 4 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2017-11-23 | — | — | US | disclosed |
| EP-3046587-A1 | PROTEIN AND PEPTIDE-FREE SYNTHETIC VACCINES AGAINST STREPTOCOCCUS PNEUMONIAE TYPE 3 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften (DE) | 2016-07-27 | — | — | EP | disclosed |
| WO-2016091399-A1 | VACCINES AGAINST STREPTOCOCCUS PNEUMONIAE SEROTYPE 4 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2016-06-16 | — | — | WO | disclosed |
| US-20160060365-A1 | HEPARAN SULFATE SYNTHESIS | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 2016-03-03 | — | — | US | disclosed |
| WO-2015040140-A1 | PROTEIN AND PEPTIDE-FREE SYNTHETIC VACCINES AGAINST STREPTOCOCCUS PNEUMONIAE TYPE 3 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2015-03-26 | — | — | WO | disclosed |
| US-20140234364-A1 | TOTAL SYNTHESIS AND IMMUNOLOGICAL EVALUATION OF SACCHARIDE MOIETIES OF THE LIPOPOLYSACCHARIDE FROM NEISSERIA MENINGITIDIS | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2014-08-21 | — | — | US | disclosed |
| EP-2683401-A1 | OLIGOSACCHARIDES AND OLIGOSACCHARIDE-PROTEIN CONJUGATES DERIVED FROM CLOSTRIDIUM DIFFICILE POLYSACCHARIDE PS-II, METHODS OF SYNTHESIS AND USES THEREOF, IN PARTICULAR AS A VACCINE | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2014-01-15 | — | — | EP | disclosed |
| US-20130344104-A1 | OLIGOSACCHARIDES AND OLIGOSACCHARIDE-PROTEIN CONJUGATES DERIVED FROM CLOSTRIDIUM DIFFICILE POLYSACCHARIDE PS-II, METHODS OF SYNTHESIS AND USES THEREOF, IN PARTICULAR AS A VACCINE | MAX-PLANCK-GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN E.V. (DE) | 2013-12-26 | — | — | US | disclosed |
| WO-2013041732-A1 | TOTAL SYNTHESIS AND IMMUNOLOGICAL EVALUATION OF SACCHARIDE MOIETIES OF THE LIPOPOLYSACCHARIDE FROM NEISSERIA MENINGITIDIS | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2013-03-28 | — | — | WO | disclosed |
| WO-2012119769-A1 | OLIGOSACCHARIDES AND OLIGOSACCHARIDE-PROTEIN CONJUGATES DERIVED FROM CLOSTRIDIUM DIFFICILE POLYSACCHARIDE PS-II, METHODS OF SYNTHESIS AND USES THEREOF, IN PARTICULAR AS A VACCINE | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e. V. (DE) | 2012-09-13 | — | — | WO | disclosed |
| US-20120142560-A1 | HEPARAN SULFATE SYNTHESIS | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2012-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11603416-B2 | Method for preparation of derivatives of gram-positive bacteria surface capsular polysaccharide | DDOST, CSGALNACT1, FUT6 | CCR6 2557/4885PAX8 4058/4885REN 1439/4885 |
| US-20170333545-A1 | VACCINES AGAINST STREPTOCOCCUS PNEUMONIAE SEROTYPE 4 | NEU4, PA2G4, STT3B | CCR6 2151/4885PAX8 2840/4885REN 3740/4885 |
| US-10669353-B2 | Preparation method of outer core octasaccharide of Helicobacter pylori lipopolysaccharide | FUT6, DDOST, FUT5 | CCR6 2726/4885PAX8 2385/4885REN 4193/4885 |
| US-20130344104-A1 | OLIGOSACCHARIDES AND OLIGOSACCHARIDE-PROTEIN CONJUGATES DERIVED FROM CLOSTRIDIUM DIFFICILE POLYSACCHARIDE PS-II, METHODS OF SYNTHESIS AND USES THEREOF, IN PARTICULAR AS A VACCINE | DDOST, PSPH, STT3B | CCR6 857/4885PAX8 4539/4885REN 4528/4885 |
| US-10174132-B2 | Heparan sulfate synthesis | HPSE, STT3B, DDOST | CCR6 1567/4885PAX8 3929/4885REN 1457/4885 |
| US-20250282806-A1 | CHEMICAL SYNTHESIS METHOD FOR DISACCHARIDE FRAGMENT OF VIBRIO VULNIFICUS BIOTYPE 2 SEROVAR A O-ANTIGEN | OGA, DDOST, FUT6 | CCR6 3535/4885PAX8 4383/4885REN 3214/4885 |
| US-11332490-B1 | Compounds and methods for treating osteoarthritis | SULT1E1, STS, ARSA | CCR6 3248/4885PAX8 3284/4885REN 1226/4885 |
| US-10052373-B2 | Protein and peptide-free synthetic vaccines against Streptococcus pneumoniae type 3 | STT3A, DDOST, LGALS3BP | CCR6 1338/4885PAX8 3010/4885REN 4154/4885 |
| US-20190177441-A1 | Preparation Method of Outer Core Octasaccharide of Helicobacter Pylori Lipopolysaccharide | FUT6, DDOST, FUT5 | CCR6 2726/4885PAX8 2385/4885REN 4193/4885 |
| US-20160060365-A1 | HEPARAN SULFATE SYNTHESIS | HPSE, STT3B, DDOST | CCR6 1567/4885PAX8 3929/4885REN 1457/4885 |
| US-20140234364-A1 | TOTAL SYNTHESIS AND IMMUNOLOGICAL EVALUATION OF SACCHARIDE MOIETIES OF THE LIPOPOLYSACCHARIDE FROM NEISSERIA MENINGITIDIS | FUT5, DAD1, STT3B | CCR6 1872/4885PAX8 4250/4885REN 2638/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.